WPC
STLN

White Pine Capital’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

White Pine Capital’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465K Buy
+85,618
New +$360K 0.11% 179

Other funds holding STLN

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
IAAG
Innovative Asset Advisors Group Shelton, Connecticut $229M AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

White Pine Capital's STLN Position: Q2 2026 in Review

White Pine Capital opened a new position in Starling Oncology Institute, Inc. Common Stock (STLN) in Q2 2026: 85,618 shares worth $465K. The stake represents 0.11% of the portfolio and ranks #179 among its holdings.

29 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • White Pine Capital held 85,618 shares of Starling Oncology Institute, Inc. Common Stock worth $465K as of Q2 2026.
  • Starling Oncology Institute, Inc. Common Stock was a new White Pine Capital position in Q2 2026.
  • Starling Oncology Institute, Inc. Common Stock made up 0.11% of White Pine Capital's portfolio in Q2 2026, its #179 holding.
  • 29 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q2 2026.

Based on White Pine Capital's 13F filing for Q2 2026, filed 5 Aug 2026.